Healthcare -
Biotechnology - NASDAQ - US
$ 36.82
0.766 %
$ 2.19 B
Market Cap
13.44
P/E
Price Target
Average
42.59%
Revenue Forecast
Estimate
63.62%
EBIT
Estimate
--41.05%
Net Income
Estimate
32.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Protagonist Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PTGX of $52.5 , with forecasts ranging from
a
low of
$38 to a high of $62 .
PTGX Lowest Price Target
Wall Street Target
38 USD
3.20%
PTGX Average Price Target
Wall Street Target
52.5 USD
42.59%
PTGX Highest Price Target
Wall Street Target
62 USD
68.39%
REVENUE FORECAST
Revenue Forecast Chart PTGX
EBIT FORECAST
EBIT Forecast Chart PTGX
NET INCOME FORECAST
Net Income Chart PTGX